Recent News

• 03.31.2025 - KALA BIO Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
• 03.05.2025 - TD Cowen 45th Annual Health Care Conference
• 02.26.2025 - KALA BIO to Present at TD Cowen 45th Annual Health Care Conference
• 02.12.2025 - KALA BIO Announces Chief Executive Officer Transition

Recent Filings

• 03.10.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.14.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 02.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 02.12.2025 - 8-K Current report
• 02.04.2025 - 424B3 Prospectus [Rule 424(b)(3)]
• 02.04.2025 - EFFECT Notice of Effectiveness
• 01.31.2025 - CORRESP Correspondence
• 01.31.2025 - UPLOAD SEC-generated letter
• 01.24.2025 - S-3 Registration statement under Securities Act of 1933
• 01.10.2025 - 4/A Statement of changes in beneficial ownership of securities